1. Phase I study of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidul)-1-nitrosourea (NSC 95466) in adults with solid tumors;Stewart;Cancer Res,1980
2. Initial clinical trials with methyl-CCNU 1(2-chloroethyl)-3-(4-methyl cyclohexyl)-nitro-sourea (MeCCNU);Young;Cancer,1973
3. Design and conduct of Phase I trials;Von Hoff,1983
4. Therapeutic response in Phase I trials of antineoplastic agents;Estey;Cancer Treat Rep,1986